tradingkey.logo
tradingkey.logo
Search

Nexalin Technology Inc

NXL
Add to Watchlist
0.361USD
-0.019-5.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
7.43MMarket Cap
LossP/E TTM

TradingKey Stock Score of Nexalin Technology Inc

Currency: USD Updated: 2026-07-02

Key Insights

Nexalin Technology Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 129 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.00.In the medium term, the stock price is expected to remain stable.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Nexalin Technology Inc's Score

Industry at a Glance

Industry Ranking
129 / 204
Overall Ranking
309 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Nexalin Technology Inc Highlights

StrengthsRisks
Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for the mental health epidemic. The Company has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety, depression and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. It has also designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 172.37% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 301.65K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 301.65K.
Overvalued
The company’s latest PE is -0.79, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.43M shares, increasing 26.88% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 6.65K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.77.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
2.000
Target Price
+426.32%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Nexalin Technology Inc?

The TradingKey Stock Score provides a comprehensive assessment of Nexalin Technology Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Nexalin Technology Inc’s performance and outlook.

How do we generate the financial health score of Nexalin Technology Inc?

To generate the financial health score of Nexalin Technology Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Nexalin Technology Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Nexalin Technology Inc.

How do we generate the company valuation score of Nexalin Technology Inc?

To generate the company valuation score of Nexalin Technology Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Nexalin Technology Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Nexalin Technology Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Nexalin Technology Inc.

How do we generate the earnings forecast score of Nexalin Technology Inc?

To calculate the earnings forecast score of Nexalin Technology Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Nexalin Technology Inc’s future.

How do we generate the price momentum score of Nexalin Technology Inc?

When generating the price momentum score for Nexalin Technology Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Nexalin Technology Inc’s prices. A higher score indicates a more stable short-term price trend for Nexalin Technology Inc.

How do we generate the institutional confidence score of Nexalin Technology Inc?

To generate the institutional confidence score of Nexalin Technology Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Nexalin Technology Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Nexalin Technology Inc.

How do we generate the risk management score of Nexalin Technology Inc?

To assess the risk management score of Nexalin Technology Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Nexalin Technology Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Nexalin Technology Inc.